These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28760045)

  • 1. Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.
    Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
    Acta Oncol; 2018 Feb; 57(2):276-282. PubMed ID: 28760045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report.
    Fernández KS; Schwartz CL; Chen L; Constine LS; Chauvenet A; de Alarcón PA
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
    Jakobsen LH; Hutchings M; de Nully Brown P; Linderoth J; Mylam KJ; Molin D; Johnsen HE; Bøgsted M; Jerkeman M; El-Galaly TC
    Br J Haematol; 2016 Apr; 173(2):236-44. PubMed ID: 26846879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's lymphoma in adolescents.
    Foltz LM; Song KW; Connors JM
    J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma in very young children: Clinical characteristics and outcome of treatment.
    Belgaumi A; Al-Kofide A; Joseph N; Jamil-Malik R; Khafaga Y; Sabbah R
    Leuk Lymphoma; 2008 May; 49(5):910-6. PubMed ID: 18464110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
    Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A
    Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.
    Kahn JM; Kelly KM; Pei Q; Bush R; Friedman DL; Keller FG; Bhatia S; Henderson TO; Schwartz CL; Castellino SM
    J Clin Oncol; 2019 Nov; 37(32):3009-3017. PubMed ID: 31539308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfavorable presentation but comparable outcome: Presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India.
    Prasad M; Narula G; Chinnaswamy G; Arora B; Shet T; Panjwani P; Sengar M; Laskar S; Khanna N; Banavali S
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27288. PubMed ID: 29893471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study.
    Gupta S; Baxter NN; Hodgson D; Punnett A; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
    Cancer Med; 2020 Oct; 9(19):6933-6945. PubMed ID: 32441450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
    J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.
    Eichenauer DA; Bredenfeld H; Haverkamp H; Müller H; Franklin J; Fuchs M; Borchmann P; Müller-Hermelink HK; Eich HT; Müller RP; Diehl V; Engert A
    J Clin Oncol; 2009 Dec; 27(36):6079-85. PubMed ID: 19901121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
    Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
    Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.
    Jhawar SR; Rivera-Núñez Z; Drachtman R; Cole PD; Hoppe BS; Parikh RR
    JAMA Oncol; 2019 May; 5(5):689-695. PubMed ID: 30605220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
    Elshenawy MA; Shahzad Rauf M; Elhassan TAM; Maghfoor I; Akhtar S
    Ann Hematol; 2018 Jul; 97(7):1229-1240. PubMed ID: 29484455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.